My story
I was delighted to join Agile Capital Markets, bringing with me over 20 years of leadership and strategic expertise in both blue chip and start-up environments. My diverse background has provided me with a deep understanding of the needs of CEOs and how to effectively help life science companies navigate complex challenges.
Previously, I was CEO of Cellnovo, I led the development and commercialization of an innovative electronic insulin micropump, raising approximately €80 million and leading the company’s successful IPO on Euronext in 2015. I was also the CEO of CIT, the largest preclinical company in France, where I led the successful rebranding of the company as Citoxlab through strategic acquisitions.
In addition to these roles, I have held several other high-impact positions, including:
- General Manager of the In Vitro Diagnostics business at J&J France
- Vice President for Northern Europe at Sorin Group (now LivaNova), with responsibility for five business units in the cardiac and dialysis sectors
- Vice President of Sales and Marketing for Europe at LifeCell, where I focused on reconstructive breast, abdominal and pelvic floor surgery.
Throughout my career, I have driven product development, industrialization, market access and commercialization across multiple geographies. Joining Agile Capital Markets is a natural progression where I can leverage my extensive experience to drive the growth and success of our clients.
I have an engineering degree in biotechnology, a PhD in immunology, and an MBA.